Ying, Wendy
Allogene Therapeutics (United States)
3 papers on CoChatORCID 0000-0002-7862-5508
Most cited papers
- Verified
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Mailankody, S., Matous, J. V., Chhabra, S., Liedtke, M., Sidana, S., Oluwole, O. O., Malik, S., Nath, R., Anwer, F., Cruz, J. C., et al. (2023) · Nature Medicine
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 257
- Verified
Adverse pregnancy outcomes and future maternal cardiovascular disease
Hauspurg, A., Ying, W., Hubel, C. A., Michos, E. D., & Ouyang, P. (2018) · Clinical Cardiology
Pregnancy and preeclampsia studiesGestational Diabetes Research and Management
Cited by 179
- Verified
Bone-related parameters are the main prognostic factors for overall survival in men with bone metastases from castration-resistant prostate cancer
Fizazi, K., Massard, C., Smith, M., Rader, M., Brown, J., Milecki, P., Shore, N., Oudard, S., Karsh, L., Carducci, M., et al. (2015) · European Urology
Prostate Cancer Treatment and ResearchBone health and treatments
Cited by 142
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free